MedTrace Logo

Transnasal Insufflation (TNI) and Chronic Obstructive Pulmonary Disease

NCT01090544 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2010-09-30

No results posted yet for this study

Summary

The purpose of this study is to determine wether transnasal insufflation as an alternate form of breathing support for COPD patients will lead to improvement of their medical condition.

Conditions

  • Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DEVICE

Nasal Insufflation

Breathing therapy

Sponsors & Collaborators

  • Helios Klinik Ambrock

    lead OTHER

Principal Investigators

  • Georg Nilius, MD · Helios Klinik Hagen Ambrock

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2010-06-30
Completion
2010-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01090544 on ClinicalTrials.gov